EUVIMEDEUVIMED entdecken
Crossref

Novel Triazole Analogues as Sgl 1 Inhibitors of Cryptococcus neoformans: An Integrative QSAR-Molecular Docking Studies

Madhu Singh, Sapna Jain Dabade, Ansari Kanij

Research Journal of Chemistry and Environment · 31.03.2026 · 5 (30) · 119

DOI: 10.25303/305rjce1190134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research Journal of Chemistry and Environment, online erschienen am 31.03.2026. Verfasst von Madhu Singh und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryptococcus neoformans (C. neoformans) infections pose a significant global burden. The current research studies aim to develop predictive QSAR models and explain how the structural characteristics of triazole derivatives contribute to Sgl1 inhibition. Moreover, molecular docking was used to determine the active molecule's mechanism of interaction with the Sgl1 enzyme's amino acid residue active site. Combining molecular docking analysis of azole derivatives with QSAR model development using GA-SMLR methods is expected to open up possibilities for the logical design of antifungal medication candidates with improved therapeutic safety and efficacy. The conventional validation parameters (R2 = 0.901, Q2 = 0.833, 𝑅𝑎𝑑𝑗 2 = 0.879, 𝑅𝑃𝑟𝑒𝑑 2 = 0.601), Golbraikh and Tropsha recommendations, Y-randomization test along with recently proposed 𝑟𝑚 2 metrics of Roy and Mitra endorse the soundness of the best selected QSAR model. These results were further complemented by ascertaining multicollinearity diagnosis analysis, VIF and tolerance statistics investigations. The modelled descriptors (HATS4e, p1c5AC, Mor28p, RDF030e and G(N..N) have highlighted the key part of few imperative properties. Further, molecular docking simulation data validated that few compounds could serve as potential Sgl1 inhibitors. The amino acid residues Glu 273, Gly 274, Try 453 and Gln 289 were found to be accountable for hydrogen bond interactions. The modeled descriptors signify the role of electronegativity, polarizability, ring structure, steric hindrance along with the presence of heteratom (specially nitrogen containing fragment) to explain the inhibitory activity of these triazole derivatives in modulating antifungal activity. The current investigation paves new dimension in the expansion of innovative antifungal therapies against C. neoformans. Subsequently, these studies would open up new dimensions for the optimization of innovative triazole antifungal candidate(s) as Sgl 1 inhibitors of Cryptococcus neoformans.

Zitieren

APA

Singh, M., Dabade, S. J., & Kanij, A. (2026). Novel Triazole Analogues as Sgl 1 Inhibitors of Cryptococcus neoformans: An Integrative QSAR-Molecular Docking Studies. Research Journal of Chemistry and Environment, 5(30), 119. https://doi.org/10.25303/305rjce1190134

Vancouver

Singh M, Dabade SJ, Kanij A. Novel Triazole Analogues as Sgl 1 Inhibitors of Cryptococcus neoformans: An Integrative QSAR-Molecular Docking Studies. Research Journal of Chemistry and Environment. 2026;5(30):119. doi:10.25303/305rjce1190134

BibTeX
@article{Singh2026,
  author = {Singh, Madhu and Dabade, Sapna Jain and Kanij, Ansari},
  title = {Novel Triazole Analogues as Sgl 1 Inhibitors of Cryptococcus neoformans: An Integrative QSAR-Molecular Docking Studies},
  journal = {Research Journal of Chemistry and Environment},
  year = {2026},
  volume = {5},
  number = {30},
  pages = {119},
  doi = {10.25303/305rjce1190134}
}
Kostenlos starten →